Product Overview
ATI-2341 acetate(1337878-62-2 free base) | T6764L | TargetMol Chemicals
CAS: T6764L
Smiles: CCCCCCCCCCCCCCCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CC(C)C)=O)CCCNC(N)=N)=O)CC1=CC=C(C=C1)O)=O)CCCCN)=O)CC(O)=O)=O)[C@H](O)C)=O)CCSC)=O)CO)=O)CCCNC(N)=N)=O)CC(C)C)=O)CCCCN)=O)CCCCN)=O)CCC(N)=O)=O)CC2=CC=C(C=C2)O)=O)=O)CCSC)=O.CC(O)=O
Formula: C106H182N26O27S2
Pathway: Autophagy|||GPCR/G Protein|||Immunology/Inflammation
Target: CXCR
Receptor: N/A
Bioactivity: ATI-2341 acetate is an effective allosteric agonist of CXCR4, it activates Gα1 instead of Gα13. ATI-2341 acetate activates inhibitory heterotrimeric G protein (GI) to promote the inhibition of cAMP production and induce calcium mobilization.
Molecular Weight: 2316, 87
